Browsing by Author "Di Pietro, Alessandra"

Sort by: Order: Results:

  • Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trial
    Powles, Thomas; Sridhar, Srikala S.; Loriot, Yohann; Bellmunt Molins, Joaquim, 1959-; Mu, Xinmeng Jasmine; Ching, Keith A.; Pu, Jie; Sternberg, Cora N.; Petrylak, Daniel P.; Tambaro, Rosa; Dourthe, Louis M.; Alvarez-Fernandez, Carlos; Aarts, Maureen; Di Pietro, Alessandra; Grivas, Petros; Davis, Craig B. (Nature Research, 2021)
    In a recent phase 3 randomized trial of 700 patients with advanced urothelial cancer (JAVELIN Bladder 100; NCT02603432 ), avelumab/best supportive care (BSC) significantly prolonged overall survival relative to BSC alone ...
  • Exploratory analyses of treatment subgroup interaction by PD-L1 status and according to PD-L1 expression in the JAVELIN Bladder 100 trial
    Climent, Miguel Ángel; Álvarez, Carlos; Morales-Barrera, Rafael; Maroto, Pablo; Rodríguez-Vida, Alejo; Méndez-Vidal, María José; García del Muro, Xavier; Puente, Javier; Láinez, Nuria; Vázquez, Sergio; Castellano, Daniel; Gómez Lang, Carmen; Wang, Jing; Di Pietro, Alessandra; Davis, Craig; Sanz Castillo, Belén; Bolós, M. Victoria; Valderrama, Begoña P. (Springer, 2024)
    Purpose: Post hoc analysis of the JAVELIN Bladder 100 trial of avelumab maintenance in locally advanced/metastatic urothelial carcinoma (la/mUC) to determine the interaction by programmed death ligand 1 (PD-L1) status for ...

Search DSpace

Browse

My Account

In collaboration with Compliant to Partaking